Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Shock Article
This is a selection made from among articles on Drug Treatment Shock. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Drug Alcohol Treatment Centers
By Allan Wilson
An addictive drug is one that causes uncontrollable and compulsive drug craving, seeking and the use of the drug, even if one is aware of negative effects and social implications. A person starts getting physically dependent on such drugs or alcohol, requiring it to pursue even day-to-day activities.
In absence of availability of the alcohol or drugs, a person feels lost and irritated. The lack starts affecting the normal behavior and such a person just cannot function till he/she is able to take a shot of that particular drug. A person might also turn to crime to lay hands on the banned substance. The figures revealed via extensive research on the cases brought to the various drug and alcohol rehabs or treatment centers give a clear indication how deep the abuse has seeped into society.
An addiction usually starts from a single try, after which, the repeated use ultimately results in being addicted to the substance. An addict requires lot of strength and courage to accept that he/she is addicted. This is usually the first step towards de-addiction. However, addicts require lot of help and support, as well as love and acceptance to kick off the habit.
Treatment centers:
Approaching the drug and alcohol rehabs or treatment centers is the best way to get rid of addiction. There are various Rehabilitation Centers across the globe, which help addicts to give up the craving. An addict might choose the drug and alcohol rehabs or treatment centers either by self-will or forcefully, by the way of family or peer pressure or a court ruling.
The drug and alcohol rehabs or treatment centers help to bring about a change from the negative behavior and addiction, to a normal healthy lifestyle. Going through the procedures within the drug and alcohol rehabs or treatment centers involves a very emotional decision for the addict, as well as the family members and friends.
Withdrawals:
A rehab program will require great determination and constraint from the addict to come out of the addiction and stay drug or alcohol free. In many cases, after successfully coming out of addiction, a person succumbs again, after initial restraint ranging from few weeks to a couple of months. This is usually because addictive drugs remain as stresses in the fats of the body and they are released in small quantities into the blood stream if a person goes through stress or anxiety.
In the face of these “small kicks”, the body craves for more drugs or alcohol leading a person back into addiction. Every person that walks into a rehab center is a different individual, with different physical and psychological factors leading the condition and different reasons to use drugs or alcohol. Different people will have different addictions and hence, they cannot be treated in a same manner. It is the responsibility of the drug and alcohol rehabs or treatment centers to provide all possible support and motivation to an addict as well as provide all help and treatment, to lead a normal and healthy life.
Allan Wilson owns and operates http://www.drug-rehab-detox.com
Article Source: http://EzineArticles.com/?expert=Allan_Wilson
http://EzineArticles.com/?Drug-Alcohol-Treatment-Centers&id=670905
Drug Treatment Shock Specific links
Drug Treatment Shock News
President Obama smoked pot in high school. Why is he against legalizing marijuana?
When he was “drug czar” in the administration of George H. W. Bush, William Bennett was asked if he’d ever smoked marijuana.
Read more...Shock Therapy: New Twist on an Old Treatment for Depression
WINSTOM-SALEM, NC ( Ivanhoe Newswire) -- One in 10 adults suffers from some type of depression. Medications and psychotherapy are common treatments, but for many, they just don't work. Now, a treatment considered barbaric decades ago is making a bi ...
Read more...Curis Announces Collaborators' Presentation of Erivedge(TM) and Debio 0932 Clinical Data at ASCO Annual Meeting
LEXINGTON, Mass. -- Curis, Inc. , a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that several abstracts on its ...
Read more...GlaxoSmithKline and AstraZeneca invest in antibiotic research
Drugmakers join forces in ÂŁ180m research in battle against threat from bugs' resistance to antibiotics Britain's two biggest drugmakers have joined forces in a ÂŁ180m research collaboration in the battle against the growing threat from bugs' resistance to antibiotics. As new drug resistant superbugs such as the "New Delhi" bug have emerged, GlaxoSmithKline and AstraZeneca have teamed up with ...
Read more...Chattanoogan.com - Chattanooga's source for breaking local news
Terry Thomas appeals the revocation of his community corrections sentence in a recent case before the Tennessee Court of Criminal Appeals, claiming that the trial court erred by ordering him back to confinement for a twenty year sentence after a failed drug test.
Read more...Carrie Fisher divulges on shock therapy, addiction, recovery to Ohio State
Carrie Fisher visited OSU for her first time May 24 in Mershon Auditorium. It’s not often that a university hosts a princess. But those attending Carrie Fisher’s speech at the Mershon Auditorium caught a glimpse of one from a galaxy far, far away.
Read more...Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN® in Combination with the Redox Modulating Agent Motexafin ...
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the initiation of a Phase 2 study evaluating ZEVALIN® Injection for intravenous use + rituximab in combination with motexafin gadolinium in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin ...
Read more...Spectral Diagnostics to present at BioFinance 2012
TORONTO , May 17, 2012 /CNW/ - Spectral Diagnostics Inc., (TSX:SDI, OTCQX: DIAGF), a Phase III company developing the first theranostic treatment for patients with septic shock, today announced that Dr. ...
Read more...Wellstat Grants BTG European Distribution Rights to Investigational Antidote for 5-FU Overexposure
Wellstat Therapeutics Corporation announced today that it has granted Named Patient supply rights and an option to obtain marketing rights in the European Union for the company’s investigational drug uridine triacetate to the specialist healthcare company BTG International Inc.
Read more...Nanotherapeutics Initiates Phase 2 Clinical Trial for Treatment of Post Traumatic Stress Disorder
Nanotherapeutics is assessing the safety of its drug for treating PTSD - post traumatic stress disorder. About 300,000 veterans of the recent wars are estimated to be affected by PTSD or major depression.Alachua, FL (PRWEB) May 23, 2012 Nanotherapeutics, Inc., today announced initiation of a Phase 2 clinical trial for the treatment of Post Traumatic Stress Disorder (PTSD) with PRX-3140. The ...
Read more...